MedTrace Logo

Study of Inactivated Poliovirus Vaccine Given at an Earlier Schedule With Shorter Intervals

NCT00260312 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2005-12-01

No results posted yet for this study

Summary

The purpose of this study was to evaluated the effectiveness of inactivated poliovirus vaccine at a vaccine schedule that is commonly used in developing countries. The effectiveness of inactivated poliovaccine given at this schedule is important to national policy makers as they consider vaccination policies after the use of oral polio vaccine is discontinued.

Conditions

  • Level of Immunity Against Poliovirus Infection

Interventions

BIOLOGICAL

Inactivated Polio Vaccine given at an accelerated schedule

Sponsors & Collaborators

Principal Investigators

  • Miguel Galindo, MD · Ministry of Public Health, Cuba

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Weeks
Max Age
2 Months
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-08-31
Completion
2003-01-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00260312 on ClinicalTrials.gov